mr ANDREW SIRACUSE — Lobbyist Profile | Poliscope

mr ANDREW SIRACUSE

Reported covered position: Sr. Tax Cnsl., Sen. John Cornyn; Staff Dir., Sen. Fin. Cmte. Int'l. Trade, Customs & Global Comp. Sbcmte., Tax Cnsl., Sen. Cornyn; Cnsl. Sen. Cornyn; Staff Dir. Sen. Fin. Cmte, Energy, Nat. Res. Sbcmte.; LA, Sen. Cornyn; LA, Sen. Norm Coleman

Filings

Clients

Firms

Years active

2025–2026

Associated filing income

$2,200,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
CELANESE CORPORATION	6	2025–2026
ACADIA PHARMACEUTICALS INC	5	2025–2026
AON RISK SERVICES, INC.	5	2025–2026
ILLINOIS TOOL WORKS INC.	5	2025–2026
IPSEN BIOPHARMACEUTICALS, INC.	5	2025–2026
MODERNA, INC.	5	2025–2026

Lobbying firms

Firm	Filings	Years
HOLLAND & KNIGHT LLP	60	2025–2026

Bills explicitly cited in this lobbyist’s assigned issues (2)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 6055

SEMI Investment Act

Client: ENTEGRIS, INC. · Firm: HOLLAND & KNIGHT LLP

Open original LDA filing ↗

Cited source text

Issues related to Section 48D of the Internal Revenue Code and Section 107 of the Chips and Science Act; S. 1642 and H.R. 6055 - Strengthening Essential Manufacturing and Industrial Investment Act.

S. 1642

SEMI Investment Act

Client: ENTEGRIS, INC. · Firm: HOLLAND & KNIGHT LLP

Open original LDA filing ↗

Cited source text

Issues related to Section 48D of the Internal Revenue Code and Section 107 of the Chips and Science Act; S. 1642 and H.R. 6055 - Strengthening Essential Manufacturing and Industrial Investment Act.

Original LDA source filings (60)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

CELANESE CORPORATION via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

International tax issues.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

OCCIDENTAL PETROLEUM CORPORATION via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $140,000Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 56 more original filings

IPSEN BIOPHARMACEUTICALS, INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ILLINOIS TOOL WORKS, INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DELL TECHNOLOGIES INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: SENATE

ASURION, LLC via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AON RISK SERVICES, INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ACADIA PHARMACEUTICALS INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

QNITY ELECTRONICS, INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Implementation of the CHIPS and Science Act, including the Investment Tax Credit authorized under Section 107 of the Act.

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

ENTEGRIS, INC. via HOLLAND & KNIGHT LLP

2026 · third_quarter · Q3

Firm income: $90,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Issues related to Section 48D of the Internal Revenue Code and Section 107 of the Chips and Science Act; S. 1642 and H.R. 6055 - Strengthening Essential Manufacturing and Industrial Investment Act.

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office

CELANESE CORPORATION via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $90,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

International tax issues.

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

ILLINOIS TOOL WORKS, INC. via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE WESTERN UNION COMPANY via HOLLAND & KNIGHT LLP

2026 · second_quarter · 2T

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MODERNA, INC. via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VERTEX PHARMACEUTICALS INCORPORATED via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ACADIA PHARMACEUTICALS INC. via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IPSEN BIOPHARMACEUTICALS, INC. via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DELL TECHNOLOGIES INC. via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: SENATE

ASURION, LLC via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AON RISK SERVICES, INC. via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OCCIDENTAL PETROLEUM CORPORATION via HOLLAND & KNIGHT LLP

2026 · second_quarter · Q2

Firm income: $140,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Energy tax policy.

Filing targets: Energy, Dept of

CELANESE CORPORATION via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OCCIDENTAL PETROLEUM CORPORATION via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $140,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Energy tax policy.

Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), SENATE, Treasury, Dept of

ACADIA PHARMACEUTICALS INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VERTEX PHARMACEUTICALS INCORPORATED via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE WESTERN UNION COMPANY via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MODERNA, INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IPSEN BIOPHARMACEUTICALS, INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ILLINOIS TOOL WORKS, INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DELL TECHNOLOGIES INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: SENATE

ASURION, LLC via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AON RISK SERVICES, INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ASURION, LLC via HOLLAND & KNIGHT LLP

2026 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

DELL TECHNOLOGIES INC. via HOLLAND & KNIGHT LLP

2026 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

CELANESE CORPORATION via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · 4A

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CELANESE CORPORATION via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

OCCIDENTAL PETROLEUM CORPORATION via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $140,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Energy tax regulations and guidance.

Filing targets: Energy, Dept of, Treasury, Dept of

VERTEX PHARMACEUTICALS INCORPORATED via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE WESTERN UNION COMPANY via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MODERNA, INC. via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IPSEN BIOPHARMACEUTICALS, INC. via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ILLINOIS TOOL WORKS, INC. via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FMC CORPORATION via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · 4T

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALKERMES, INC. via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · 4T

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ACADIA PHARMACEUTICALS INC. via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AON RISK SERVICES, INC. via HOLLAND & KNIGHT LLP

2025 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate income tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FMC CORPORATION via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CELANESE CORPORATION via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform 2025.

Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of

VERTEX PHARMACEUTICALS INCORPORATED via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

MODERNA, INC. via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IPSEN BIOPHARMACEUTICALS, INC. via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ALKERMES, INC. via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ACADIA PHARMACEUTICALS INC. via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

ILLINOIS TOOL WORKS, INC. via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform 2025.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AON RISK SERVICES, INC. via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Tax Reform 2025.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

THE WESTERN UNION COMPANY via HOLLAND & KNIGHT LLP

2025 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FMC CORPORATION via HOLLAND & KNIGHT LLP

2025 · third_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.

THE WESTERN UNION COMPANY via HOLLAND & KNIGHT LLP

2025 · third_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TAX

Taxation/Internal Revenue Code

Corporate Income Tax.